CARISMA to Present New Data at The Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting

November 9, 2020


PHILADELPHIANov. 9, 2020 /PRNewswire/ — CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced new preclinical findings accepted for presentation at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting (November 9 – 14, 2020). Click here for more information.